TFA Therapeutics RAJAF
OTC RAJAF
$9.18 +0.00 (+0.00%)
At close: Nov 9, 2026 · 4:00 PM EST

TFA Therapeutics (RAJAF) Short term Debt (2022 - 2025)

Updated

TFA Therapeutics' Short term Debt came in at $465,233 for Q4 2025, up 3.8% from $448,155 a year earlier.

Analysis

TFA Therapeutics (RAJAF) Short term Debt (2022 - 2025) Analysis & Trends

  • Going back by year, Short term Debt was $448,155 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Procter & Gamble 390.78 Bn 342.58 Bn 11.60 Bn
2 Colgate Palmolive 77.96 Bn 72.79 Bn 3.23 Bn
3 Estee Lauder Companies 41.21 Bn 28.31 Bn 2.81 Bn
4 Kenvue 37.02 Bn 32.73 Bn 2.31 Bn
5 Kimberly Clark 36.84 Bn 32.92 Bn 1.44 Bn
6 Church & Dwight 26.38 Bn 24.77 Bn 749.40 Mn
7 Clorox 12.88 Bn 11.29 Bn 770.00 Mn
8 e.l.f. Beauty 7.00 Bn 5.82 Bn 370.22 Mn
9 Reynolds Consumer Products 5.26 Bn 4.95 Bn 236.00 Mn
10 TFA Therapeutics 1.02 Bn 1.02 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 465,233.00
Dec 31, 2024 448,155.00
Dec 31, 2022 414,000.00
API Access

TFA Therapeutics Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=RAJAF&period=max&api_key=YOUR_API_KEY